$31.53
0.190.61%
At Close: -
$31.60
0.070.22%
After Hours: 4:46 PM EDT
15 minutes delayed
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
05/06/2024 | IART | Integra Lifesciences | FY | 2024 | $3.01 | $3.11 | $3.19 | $1.67B | $1.69B | $1.62B | Get Alert |
05/06/2024 | IART | Integra Lifesciences | Q2 | 2024 | $0.60 | $0.65 | $0.75 | $411.00M | $416.00M | $395.80M | Get Alert |
02/28/2024 | IART | Integra Lifesciences | FY | 2024 | $3.15 | $3.25 | $3.44 | $1.60B | $1.62B | $1.62B | Get Alert |
02/28/2024 | IART | Integra Lifesciences | Q1 | 2024 | $0.53 | $0.57 | $0.74 | $360.00M | $365.00M | $380.89M | Get Alert |
10/25/2023 | IART | Integra Lifesciences | FY | 2023 | $3.10 | $3.14 | $3.14 | $1.54B | $1.55B | $1.55B | Get Alert |
10/25/2023 | IART | Integra Lifesciences | Q4 | 2023 | $0.89 | $0.93 | $0.78 | $397.00M | $403.00M | $387.12M | Get Alert |
07/26/2023 | IART | Integra Lifesciences | Q3 | 2023 | $0.76 | $0.80 | $0.97 | $386.00M | $390.00M | $411.86M | Get Alert |
07/26/2023 | IART | Integra Lifesciences | FY | 2023 | $3.10 | $3.18 | $3.12 | $1.55B | $1.56B | $1.56B | Get Alert |
05/23/2023 | IART | Integra Lifesciences | Q2 | 2023 | $0.55 | $0.59 | $0.77 | $372.00M | $376.00M | $398.13M | Get Alert |
04/26/2023 | IART | Integra Lifesciences | FY | 2023 | $3.43 | $3.51 | $3.48 | $1.60B | $1.62B | $1.61B | Get Alert |
04/26/2023 | IART | Integra Lifesciences | Q2 | 2023 | $0.75 | $0.79 | $0.85 | $396.00M | $400.00M | $404.78M | Get Alert |
02/22/2023 | IART | Integra Lifesciences | FY | 2023 | $3.43 | $3.51 | $3.52 | $1.60B | $1.62B | $1.62B | Get Alert |
02/22/2023 | IART | Integra Lifesciences | Q1 | 2023 | $0.72 | $0.76 | $0.79 | $370.00M | $376.00M | $381.72M | Get Alert |
01/25/2023 | IART | Integra Lifesciences | FY | 2022 | $3.34 | $3.38 | $3.30 | — | — | — | Get Alert |
01/25/2023 | IART | Integra Lifesciences | Q4 | 2022 | $0.92 | $0.96 | $0.89 | — | — | — | Get Alert |
01/10/2023 | IART | Integra Lifesciences | FY | 2022 | $3.33 | — | $3.30 | $1.56B | $1.56B | $1.56B | Get Alert |
01/10/2023 | IART | Integra Lifesciences | Q4 | 2022 | $0.91 | — | $0.89 | $397.00M | $398.00M | $397.50M | Get Alert |
10/26/2022 | IART | Integra Lifesciences | FY | 2022 | $3.29 | $3.33 | $3.15 | $1.55B | $1.56B | $1.56B | Get Alert |
10/26/2022 | IART | Integra Lifesciences | Q4 | 2022 | $0.87 | $0.91 | $0.88 | $391.00M | $403.00M | $403.50M | Get Alert |
08/24/2022 | IART | Integra Lifesciences | FY | 2022 | $3.12 | $3.20 | $3.24 | $1.55B | $1.57B | $1.57B | Get Alert |
08/24/2022 | IART | Integra Lifesciences | Q3 | 2022 | $0.69 | $0.73 | $0.80 | $374.00M | $382.00M | $387.79M | Get Alert |
07/27/2022 | IART | Integra Lifesciences | FY | 2022 | $3.21 | $3.29 | $3.31 | $1.56B | $1.57B | $1.59B | Get Alert |
07/27/2022 | IART | Integra Lifesciences | Q3 | 2022 | $0.78 | $0.82 | $0.84 | $383.00M | $391.00M | $398.66M | Get Alert |
04/27/2022 | IART | Integra Lifesciences | Q2 | 2022 | $0.78 | $0.82 | $0.80 | $392.00M | $400.00M | $394.32M | Get Alert |
04/27/2022 | IART | Integra Lifesciences | FY | 2022 | $3.27 | $3.35 | $3.31 | $1.58M | $1.60B | $1.59B | Get Alert |
02/23/2022 | IART | Integra Lifesciences | Q1 | 2022 | $0.67 | $0.71 | $0.73 | $357.00M | $365.00M | $378.50M | Get Alert |
02/23/2022 | IART | Integra Lifesciences | FY | 2022 | $3.27 | $3.35 | $3.42 | $1.58B | $1.60B | $1.63B | Get Alert |
01/11/2022 | IART | Integra Lifesciences | FY | 2021 | — | — | — | $1.54B | $1.54B | $1.54B | Get Alert |
01/11/2022 | IART | Integra Lifesciences | Q4 | 2021 | — | — | — | $404.00M | $406.00M | $403.94M | Get Alert |
11/02/2021 | IART | Integra Lifesciences | Q4 | 2021 | $0.82 | $0.86 | $0.81 | $403.00M | $403.00M | $409.65M | Get Alert |
11/02/2021 | IART | Integra Lifesciences | FY | 2021 | $3.16 | $3.20 | $3.02 | $1.54B | $1.55B | $1.54B | Get Alert |
07/28/2021 | IART | Integra Lifesciences | Q3 | 2021 | $0.71 | $0.74 | $0.74 | $382.00M | $389.00M | $389.25M | Get Alert |
07/28/2021 | IART | Integra Lifesciences | FY | 2021 | $2.98 | $3.05 | $2.92 | $1.54B | $1.55B | $1.53B | Get Alert |
05/20/2021 | IART | Integra Lifesciences | Q2 | 2021 | $0.67 | $0.67 | $0.66 | $378.00M | $378.00M | $375.03M | Get Alert |
05/20/2021 | IART | Integra Lifesciences | FY | 2021 | $2.93 | $2.93 | $2.92 | $1.52B | $1.53B | $1.53B | Get Alert |
04/28/2021 | IART | Integra Lifesciences | FY | 2021 | $2.93 | $2.93 | $2.90 | $1.52B | $1.53B | $1.53B | Get Alert |
04/28/2021 | IART | Integra Lifesciences | Q2 | 2021 | $0.63 | $0.67 | $0.67 | $372.00M | $378.00M | $370.53M | Get Alert |
02/18/2021 | IART | Integra Lifesciences | FY | 2021 | $2.86 | $2.93 | $2.92 | $1.52B | $1.53B | $1.54B | Get Alert |
02/18/2021 | IART | Integra Lifesciences | Q1 | 2021 | $0.54 | $0.58 | $0.64 | $345.00M | $355.00M | $359.90M | Get Alert |
01/14/2021 | IART | Integra Lifesciences | Q4 | 2020 | — | — | — | $387.00M | $389.00M | $389.05M | Get Alert |
01/14/2021 | IART | Integra Lifesciences | FY | 2020 | — | — | — | $1.37B | $1.37B | $1.37B | Get Alert |
10/06/2020 | IART | Integra Lifesciences | Q3 | 2020 | — | — | — | $368.00M | $370.00M | $340.39M | Get Alert |
07/09/2020 | IART | Integra Lifesciences | Q2 | 2020 | — | — | — | $254.00M | $256.00M | $240.49M | Get Alert |
04/07/2020 | IART | Integra Lifesciences | Q1 | 2020 | — | — | — | $352.00M | $354.00M | $367.38M | Get Alert |
02/19/2020 | IART | Integra Lifesciences | FY | 2020 | $3.00 | $3.05 | $3.00 | $1.55B | $1.57B | $1.59B | Get Alert |
01/14/2020 | IART | Integra Lifesciences | FY | 2020 | — | — | — | $1.55B | $1.57B | $1.60B | Get Alert |
01/14/2020 | IART | Integra Lifesciences | FY | 2019 | — | — | — | $1.52B | $1.52B | $1.53B | Get Alert |
01/14/2020 | IART | Integra Lifesciences | Q4 | 2019 | — | — | — | $395.00M | $395.00M | $397.91M | Get Alert |
10/24/2019 | IART | Integra Lifesciences | FY | 2019 | $2.70 | $2.75 | $2.73 | $1.52B | $1.52B | $1.52B | Get Alert |
The last reported Earnings numbers were from May 6, 2024 for the full year 2024 and was for an earnings per share guidance in the range of $3.01 and $3.11 versus the estimated EPS of $3.19.
Browse guidance and forecast on all stocks.